Amarin Corp Plc (AMRN)

[ziploc_1]

The main thrust of the Respect study was to debunk the canard that the MO placebo used in the Reduce-It study was the source of the excellent results wherein Vascepa showed a reduction of CVD.

The Jelis study had not used a MO placebo, but the myth that MO playing a role in the positive results of Reduce-It was still bandied about(even though Jelis seemed to prove otherwise)....the Respect study also did not use a MO placebo and the results were very similar to those of Jelis...This should put the MO matter to rest for all unbiased observers.